
Saventic Health sp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Saventic Health is a company that utilizes AI-driven technology to streamline clinical trials, diagnostics, and treatment pathways for rare diseases. It provides tools to identify high-risk patients faster and more accurately, facilitating recruitment for clinical studies and improving patient outcomes. Additionally, Saventic Health offers integration with hospital EMRs and a global online application for patients and caregivers to manage the patient journey.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 86 days late).
- 202501/07/2026
- 202418/06/2025
- 202318/06/2024
- 202214/07/2023
- 202109/10/2022
- 202030/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Diagnostic software
- AI Algorithms
- Medical data analysis
- Patient identification
- Clinical trial management
- Patient platform
Websites
The company has 5 websites, including 2 versions for foreign markets (e.g. Germany, Brazil). Most of them run on WordPress. The sites are available in: Polish, English, German, French, Spanish and 7 more. The company uses the Meta advertising pixel (Facebook, Instagram).
- saventic.comSaventic Health: Find patients with rare diseases 6x fasterWordPress 7.1ElementorYoast SEOWWPMLNginx
- bloodlab.plInterpretacja wyników badań laboratoryjnych online, wyniki badań – analiza, znaczenie | BloodlabGoogle Tag ManagerMeta PixelNginx
- saventiccare.comSaventic Care – Your AI Partner in Rare Disease DiagnosisWordPress 7.1ElementorGoogle Tag ManagerYoast SEOWWPMLCloudflare
Authorized Representatives
Manner of representation
The following are authorised to submit declarations concerning the company's property rights and obligations and to sign on behalf of the company: A. in the case of a multi-member management board: two members of the management board acting jointly always with the President of the Management Board, if appointed, and the Vice-President of the Management Board, if appointed; B. in the case of a one-person management board: one member of the management board independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 132 | $1,782.82 | 15.7706% | |
Grzegorz Władysław Basak age 48 | 141 | $1,904.38 | 16.8459% |
Karol Lis age 39 | 111 | $1,499.19 | 13.2616% |
| 108 | $1,458.67 | 12.9032% | |
Szymon Piotr Piątkowski age 46 | 225 | $3,038.90 | 26.8817% |
Others | 120 | $1,620.75 | 14.337% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-12-01.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 5, 2024 | Call to creditors |
Public aid
14 public aid cases recorded, with a total value of $2,175,671.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 30, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $394$394 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Aug 8, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $696$696 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Aug 8, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $691$691 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-05-01 | Development of an innovative algorithmic engine using artificial intelligence and new knowledge derived from a large set of real-world medical data to support physicians in the earlier detection and treatment of iron deficiencies based on blood count results and other diagnostic tests. | $1M$1,017,508 | European Funds for a Modern Economy | |
| 2025-05-01 | Development of a support engine that uses advanced artificial intelligence methods and machine capacity to process millions of patient records in a sufficiently short time to detect the risk of rheumatic diseases early, thereby supporting the diagnostic process performed by a physician. | $754K$753,953 | European Funds for a Modern Economy | |
| 2020-12-01 | Development and implementation of an innovative machine-learning-based diagnostic process to shorten the patient pathway and improve the quality of healthcare for patients with lympho- and myeloproliferative diseases. | $344.7K$344,748 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Proacta S.A. | $3,747,821.54 | proacta.pl | ||
| Upside Lab sp. z o.o. | $1,468,774.96 | upsidelab.io | ||
| Medplace.Pl sp. z o.o. | $1,248,874.05 | medplace.pl | ||
| Alcid sp. z o.o. | $1,230,813.28 | alcid.pl | ||
| Gradis sp. z o.o. | $1,058,511.36 | gradis.pl | ||
| Mindz It sp. z o.o. + limited partnership | $915,679.93 | mindz.it | ||
| Nivalit sp. z o.o. | $862,615.26 | nivalit.com | ||
| Precisionlife Poland sp. z o.o. | $617,020.34 | precisionlife.com | ||
| Inovintell sp. z o.o. | $420,638.70 | inovintell.com | ||
| Lifestyle-Med sp. z o.o. | $146,784.32 | lifestyle-med.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-12-09 | Share capital increase (41,550.00 PLN → 41,850.00 PLN) | |
| 2025-03-17 | Share capital increase (13,850.00 PLN → 41,550.00 PLN) | |
| 2025-01-16 | Share capital increase (13,050.00 PLN → 13,850.00 PLN) | |
| 2024-10-31 | Share capital increase (12,600.00 PLN → 13,050.00 PLN) | |
| 2024-10-16 | Share capital reduction (13,550.00 PLN → 12,600.00 PLN) |
FAQ
Last updated: 2026-07-09
